Urgent Care Apps Market- trends, Global Analysis, Report, Size Share

 The large strides by the healthcare industry has successfully led to high surgical outcomes as well as ensured long life of patients. Mobile applications have been adopted by the sector for controlling the large patient inflow. Urgent care apps are applications made for patients for multipurpose uses such as making appointments, settling bills, and provide effective patient care. The global urgent care apps market report by Market Research Future (MRFR) contains insights gained from painstaking primary and secondary research by analysts. It has an in-depth analysis of the penetration of mobile applications combined with predictions for the period of 2018 to 2023 (forecast period).

Get Free Sample Copy of "COVID-19 Pandemic Impact on Urgent Care Apps Market @ https://www.marketresearchfuture.com/sample_request/6677 

Urgent Care Apps Market Scope

The global urgent care apps market valuation can touch USD 2,597.8 million by 2023. It stood at USD 314.2 million in 2017. The market is predicted to showcase a CAGR of 42.20% over the forecast period. This can be attributed to the increasing inclination towards personalized apps and the preference for home healthcare. Increasing costs of healthcare is another factor contributing to this trend. Urgent care apps have reduced waiting queues and prevent ER costs to spiral.

High penetration of smartphones and tablets and the move towards digitization by the healthcare industry will facilitate global market growth. Product offerings by urgent care manufacturers for catering to various strata of the healthcare industry and streamlining of workflow can bode well for the market. The transition to patient-centric models will lead to qualitative care and manage patients without the need for a physical presence. These apps can monitor health parameters, sleep patterns, and drug intake for the betterment of patients.

But connectivity issues in developing regions may pose a challenge to the global urgent care apps market growth.

Urgent Care Apps Market Segmentation

The global urgent care apps market is segmented by type and clinical area.

By type, it is segmented into in-hospital communication & collaboration apps, emergency care triage apps, and post-hospitalization apps. Post-hospital apps are further segmented into rehabilitation apps, medication management apps, and care provider communication & collaboration apps.

By clinical area, it is segmented into cardiac conditions, stroke, trauma, and others. The trauma segment held the largest market share owing to large number of road accidents and awareness campaigns by healthcare organizations for addressing effects of trauma. However, the cardiac conditions segment can generate the maximum revenue owing to large number of cardiovascular diseases.  

Regional Analysis

The Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC) are regions analyzed in the global urgent care apps market.

The Americas is bound to dominate the global market till 2023 owing to the well-developed healthcare framework and insurance coverage schemes by countries in North America. The penetration of low-latency communication technologies and smartphones has worked in favor of the global urgent care apps market. Awareness of the applications and the focus on personalized care can lead to faster growth of the market in the region.

Europe can exhibit a stellar growth rate during the forecast period owing to initiatives by governments in the region for curtailing healthcare costs. On the other hand, the APAC region can be lucrative for the market due to openness of doctors and patients towards mobile apps. Furthermore, the need for patient-focused applications as well as other medical platforms for offering practical guidance to patients can bode well for the market in the region.

Urgent Care Apps Market Competition Outlook

Alayacare, Imprivata, Vocera Communications, Voalte, Pulsara, Pivot Design Group, Twiage, Argusoft, Siilo, Johnson & Johnson, Forward Health, TigerConnect, Hospify, PatientSafe Solutions, and Allm are key players in the global urgent care apps market. Development of healthcare management information system applications, electronic health record (EHR) system apps, and other pertinent applications can widen the global market scope further.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/urgent-care-apps-market-6677 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Healthcare Cloud Computing Market- Industry Analysis, Top Companies, Report And Growth Factors

 Healthcare Cloud Computing Market Synopsis:

Market Research Future (MRFR) has published a report stating that the global healthcare cloud computing market is marked to expand at a remarkable growth rate in the upcoming years. Increased adoption of internet of things (IoT) in the healthcare sector of developed and developing regions are leading to the increased reliance on cloud-based services in the healthcare sector. Rise in demand for cloud-based platform to manage a large amount of unstructured data in the healthcare sector is majorly propelling the growth of the global healthcare cloud computing market. Proliferation in service providers that are coming up with innovative and optimized cloud computing solutions is also fueling the expansion of the global cloud computing market.

 

Latest Free Sample PDF Available @ https://www.marketresearchfuture.com/sample_request/6519

Healthcare Cloud Computing Market Segmentation:

The global healthcare cloud computing market has been segmented on the basis of applications, deployment, services, and end-user. Based on applications, the global Healthcare Cloud Computing Market  has been segmented into non-clinical information system (NCIS) and clinical information system (CIS). Among these, the clinical information system (CIS) segment commands for the major share in the global healthcare cloud computing market owing to the increased volume of patient data as a result of high prevalence of chronic diseases and rise in geriatric population. Based on deployment, the global healthcare cloud computing market has been segmented into private cloud, public cloud, and hybrid cloud. The private cloud segment is projected to account for the major share in the global healthcare cloud computing market owing to the higher adoption of this service due to its better security. Based on service, the global healthcare cloud computing market has been segmented into infrastructure-as-a-service (IaaS), software-as-a-service (SaaS), and platform-as-a-service (PaaS).

 

Healthcare Cloud Computing Market Regional Analysis:

Geographically, the global healthcare cloud computing market has been segmented into Latin America, Europe, North America, Asia Pacific and the Middle East and Africa. The North America region commands the major share in the global healthcare cloud computing market owing to the presence of well-developed healthcare sector, rapid adoption of cloud-based solutions, constant technological advancement and high concentration of developed economies that are expanding their funding for advancement of healthcare services in this region. The Asia Pacific region is expanding significantly in the global healthcare cloud computing market owing to the rapid development of healthcare sector in the emerging economies, rise in awareness regarding the benefits of cloud-based services, and emergence for sophisticated platform to maintain the large amount of healthcare data that is present in an unstructured manner in this region. The healthcare cloud computing market in the Europe region is expanding at a noteworthy growth rate owing to the increased availability of players that are providing cloud-based services for data storage and data management in the well-developed healthcare sector and increased healthcare expenditure by the population in this region. Poor economic conditions and low penetration of technologically advanced healthcare services in the underdeveloped countries are slowing down the growth of the healthcare cloud computing services in the Middle East and Africa region. 

 

Industry Updates:

In November 2018, ClearDATA, a Texas-based healthcare exclusive cloud provider, has secured USD 26 Mn in its latest funding as an investment for healthcare cloud computing services. 

 

In December 2018, it has been announced that Magellan Health, an American for-profit managed healthcare company, is adopting software-as-a-service (SaaS) for identity management and other functions as a part of digital transformation.

 

Healthcare Cloud Computing Market Key Players:

The major players profiled by MRFR that are operating in the global healthcare cloud computing market are International Business Machines (IBM) Corporation, CareCloud Corporation, Nuance Communications, Agfa-Gevaert N.V., Merge Healthcare Inc., Carestream Corporation, Cerner Corporation, Microsoft Corporation, Oracle Corporation, ClearData Networks Inc., Sectra AB, GE Healthcare, athenahealth Inc., NextGen Healthcare, Siemens Healthineers, and Dell Inc.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/healthcare-cloud-computing-market-6519 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Growth Analysis on Compressed Air Treatment Equipment Market

 Market Highlights

According to MRFR analysis, Global Compressed Air Treatment Equipment Market is expected to register a CAGR of 6.5 from 2020 to 2027 and hold a value of USD 12,500 Million till 2027.

 

Download Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/10343

Global Compressed Air Treatment Equipment Market is driven by several factors, such as high product penetration across various end-use industries such as F&B, pharmaceuticals, chemicals, and others, rising demand from these industries to protect air compressors from corrosion or rust, and technological advancements in the compressed air treatment equipment are augmenting the market growth.

A lot of established and emerging market players are dominating the global compressed air treatment equipment market. The prominent players are involved in strategic agreements, product launches, and joint ventures to sustain their market position. For instance, in May 2017, Atlas Copco (US) acquired Pressure Compressors Ltd (Brazil) and related manufacturers. The acquisition was carried out to help strengthen their presence in both countries, namely Brazil and US.

Access Report Details @ https://www.marketresearchfuture.com/reports/compressed-air-treatment-equipment-market-10343

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global compressed air treatment equipment market, owing to the factors such as increasing number of manufacturing facilities, presence of many F&B and pharmaceutical companies, need for optimal energy efficiency, and new technological advancements in products being used in compressed air treatment equipment. Furthermore, regulatory standards such as the ANSI/ISA Instrument Air Standard by the Instrument Society of America equipment aid significantly in the market growth.

 On the other hand, Europe is expected to hold the second position in the global compressed air treatment equipment market due to the favorable regulatory scenario supporting the compressed air treatment procedure and the presence of major giants in the market involved in merger & acquisition, regional expansion, and new product innovation. For instance, in April 2018, Atlas Copco (Sweden) introduced Smart AIR Solutions. These are complete air or gas solutions designed to provide customers with the lowest life cycle costs for their equipment.

Asia-Pacific is anticipated to be the fastest-growing region due to increasing industrialization and urbanization, stringent regulations governing emissions and treatment of industrial effluents, and the need for achieving high efficiency with mechanical equipment and factory processes.

Furthermore, the development in the countries such as Saudi Arabia and the UAE in the Middle East & Africa compressed air treatment equipment market is attributed to the technological development in compressed air treatment equipment being used in several end-use verticals, increasing number of manufacturing facilities, and rising demand for purified air.

Segmentation

Global Compressed Air Treatment Equipment Market has been segmented into Product, Application, and End-Use.

Based on the product, the market has been segregated into filters, dryers, air coolers, and others. The filters segment is expected to gain traction over the forecast period due to its advantages, such as easy-to-use filters, energy efficiency, and provision of safety and flexibility. Furthermore, the dryers segment is expected to be the fastest-growing segment during the forecast period owing to the rise in demand for such devices.

Based on application, the global compressed air treatment equipment market has been classified as plant air/shop air, process air, and instrument air and breathing air. The process air application segment is expected to lead over the forecast period. This is due to the rising demand for compressed air treatment systems across a host of industries, such as pharmaceuticals and which requires a steady supply of clean & oil-free compressed air. The process air segment is anticipated to be the fastest-growing segment owing to the rising use of compressed air treatment equipment for the process air application.

Based on end-use, the F&B segment is expected to be the fastest-growing, and the pharmaceuticals segment held the major share of the market. The global compressed air treatment equipment market is classified as chemicals, F&B, pharmaceuticals, and others. The quality of compressed air in these sectors is of utmost importance as these industries require clean air without any contamination in their operation. Increasing adoption of compressed air treatment equipment by these end-use industries and the presence of regulatory constraints are primarily driving the market growth. On the other hand, the pharmaceuticals segment held the largest share in 2019 owing to the increasing number of pharmaceutical companies using air compressors.

Key Players                                                                     

Some of the key players in the global compressed air treatment equipment market are Atlas Copco Corporation (Sweden), Airfilter Engineering (Malaysia), Alpha-Pure (US), Beko Technologies (India), BOGE Compressors (Germany), Chicago Pneumatic (India), Donaldson Company, Inc. (US), Gem Equipment’s Ltd (India), Industrial Air Power (IAP) (UK), Kaeser Compressors, Inc. (Germany), Pneumatech, Inc. (US), Pentair plc. (US), Precision Filtration Products (US), Seneca Companies, Inc. (US), Hitachi Ltd. (Japan), Sullivan-Palatek, Inc. (US), Van Air Systems (US), and Gardner Danver (US).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/ 

Veterinary POC Diagnostic Market - Global Revenue, Trends, Growth, Share, Size and Forecast

 Market Highlights

According to MRFR analysis, the Global Veterinary POC Diagnostic Market is expected to register a CAGR of 8.9% during the forecast period of 2020 to 2027 and reach USD 2,894 Million by 2027.

Changes in veterinary healthcare system like Point-of-Care (POC), it enables rapid results in non-laboratory settings. There is traction in the veterinary point-of-care diagnostics market due to the adoption of advanced and innovative diagnostic testing methods.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/10018 

The growth of the global veterinary POC diagnostic market can be attributed to the growing need for rescue medication, demand for POC diagnostic in the field of veterinary as the diseases in animals is increasing and affecting the human being as well.

Furthermore, growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for pet insurance & growing animal health expenditure, an increasing number of veterinary practitioners, increase in income levels in developed economies are expected to fuel the market growth during the forecast period.

However, the increasing pet care costs and high cost of veterinary imaging instruments are expected to restrain the growth of the global veterinary POC diagnostic market.

Several market players such as IDEXX Laboratories, Heska Corporation, and Fujifilm among others currently dominate the global veterinary POC diagnostic market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions, for instance, In January 2020, IDEXX launched the Vcheck Feline NT-proBNP test kit, In January 2020, Heska Corporation acquired SCIL Animal Care Company (Germany) to complement the company's veterinary diagnostics portfolio and expand the geographic portfolio across North America and greater Europe and reach over to 25 countries across these regions., In July 2019, Fujifilm Corporation established FUJIFILM VET Systems Co., Ltd in Japan to supply its veterinary products segment to veterinary clinical practices in the country. This expansion would enhance the company's veterinary medicine business in Japan. In January 2018, IDEXX launched the IDEXX Catalyst SDMA Test.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/veterinary-poc-diagnostic-market-10018 

Segmentation

Global Veterinary POC Diagnostic Market has been segmented based on the Product, Technology, Application, Animal Type, and End User.

Based on the type, the global veterinary POC diagnostic market has been segmented into Consumable, Instruments. The consumable segment is expected to hold the largest market share owing to the increasing demand for the rapid detection of diseases, the growing prevalence of animal zoonotic diseases.

On the basis of technology, the market has been segmented into Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, and Molecular Diagnostics. Clinical Biochemistry is expected to hold a major market share due to the higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

Based on the application, the market has been segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, Orthopedics & traumatology, Gynecology, Oncology, Cardiology, and Neurology. Clinical pathology is expected to grow at the fastest CAGR.
The market based on end user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Based on the animal type, the market has been segmented into Companion animals, Livestock Animals. Clinical pathology is expected to grow at the fastest CAGR.

Key Players

Thermo Fisher Scientific, Inc. (US), Idexx Laboratories, Inc. (US), Zoetis, Inc. (US), Virbac (France), Heska Corporation (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company Ltd. (UK), Randox Laboratories, Ltd. (UK), AniPoC, Ltd. (UK), Carestream Health, Inc. (US), Neurologica Corporation (US), Fujifilm Sonosite, Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Esaote spa (Italy), Mindray Medical International Limited (A Part of Excelsior Union Limited) (China), GE Healthcare (US), Minxray, Inc. (US), QR s.r.l. (Italy), Sedecal (Spain), Examion GmbH (Germany)

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising animal zoonotic diseases in the region. The veterinary POC diagnostic market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European veterinary POC diagnostic market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The veterinary POC diagnostic market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing zoonotic diseases, the market in Asia-Pacific is expected to be the fastest-growing. The veterinary POC diagnostic market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

   

Neurology Devices Market Set to grow with CAGR 10.2% During 2018 – 2027 – Global and Regional Analysis

 Market Highlights

According to MRFR analysis, the Global Neurology Devices Market is expected to register a CAGR of 10.2% during the forecast period of 2020 to 2027 and reach USD 21,029.7 Million by 2027.

Neurology devices are used for the treatment of neurological disorders that comprise pathophysiological conditions that affect the brain, spinal cord, and nervous system.

Get Free Sample @  https://www.marketresearchfuture.com/sample_request/9768 

The market for neurology devices is expected to grow at boost due to a surge in the prevalence of the neurological disorder, a growing aging population, increasing adoption of technologically advanced devices, and growing demand for minimally invasive devices. However, high cost and stringent regulatory government regulations are some of the factors expected to hinder the growth of the market.

The global market is expected to witness a profitable growth owing to the rise in neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors. As per the statistics of WHO in 2017, around 50 million people all over the world were affected by epilepsy. Additionally, Alzheimer's Research UK stated that over 50.8 million people worldwide were affected by dementia in 2017 and was expected to reach 55 million patients in 2020. Moreover, this number would double every 20 years, reaching 75 million by 2030 and 131.5 million by 2050. These huge prevalence of neurological disorders among the population and rising healthcare expenditure for neurological disorders are driving the growth of the neurology devices market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the increasing adoption of technological devices, favorable reimbursement scenarios, and the presence of major manufacturers among others. The neurology devices market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European neurology devices market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The neurology devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing geriatric population, the market in Asia-Pacific is expected to be the fastest-growing. The neurology devices market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/neurology-devices-market-9768  

Segmentation

The global neurology devices market has been segmented based on the product, and end user.

Based on product the market is segmented into neurostimulation, Interventional neurology, CSF management, and Neurosurgery devices. Neurostimulation segment accounted for the major market share owing to the increasing prevalence of epilepsy, Parkinson's disease, tremor, dystonia, depression, obsessive-compulsive disorder, Tourette syndrome, chronic pain, and cluster headache. The segment is further bifurcated by spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation, vagus nerve stimulation, and gastric electric stimulation.

Interventional neurology segment is divided into aneurysm coiling & embolization (embolic coils, flow diversion devices, liquid embolic agents), cerebral balloon angioplasty & stenting (carotid artery stents, filter devices, balloon occlusion devices), neurothrombectomy (clot retriever, suction aspiration devices, snares). Moreover, CSF management is further distributed into the following sub-segments, CSF shunts, and CSF drainage. The neurosurgery devices segment is further sub-segmented into ultrasonic aspirators, stereotactic systems, neuroendoscopes, and aneurysm clips. The segment is expected to grow at the fastest CAGR during the forecast period owing to the increasing demand for non-invasive neurosurgery. 

The market based on end users has been segmented into hospitals & clinics, specialty centers, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Key Players

Some of the key players in the global neurology devices market are B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson and Johnson, Medtronic Inc., St. Jude Medical, Inc., Stryker Corporation, W.L. Gore & Associates, Inc., and Esaote, among others

Related Reports

Airway Management Market

Hemorrhoid Treatment Devices Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

(2018 – 2023) Global Breast Biopsy Market, Trends, CAGR Status, Market Growth, Analysis and Forecast

 Global Breast Biopsy Market: By Product (Biopsy Needles, Biopsy Tables), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy), Guidance Technology (Ultrasound-Guided, CT-Guided Biopsy), End-Users (Hospitals, Labs) –Global Forecast Till 2023

Market Research Future (MRFR) report on the global breast biopsy market is a comprehensive research that provides a detailed overview of the market. The report covers the COVID-19 analysis of the global breast biopsy market and provides a detailed summary of market segments, current trends, growth projections, and market challenges from 2018 to 2023 (forecast period) to identify potential business opportunities.

Free Sample Copy of  With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6288  

A biopsy is a small operation performed to remove tissue from the area of concern within the body. Breast biopsy is a procedure that involves testing small samples of breast tissue to detect breast cancer. Breast biopsies are performed using minimal invasive biopsy systems due to minimal disfigurement and pain. There are various types of biopsy procedures depending on the technique, such as fine needle aspiration biopsy (FNAB), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB) prescribed by the doctor based on the size, location, and other characteristics of the breast abnormality.

 

Breast Biopsy Market Dynamics

Increased breast cancer prevalence, particularly among women over 35 years of age during menopause (more vulnerable to breast cancer) and increased awareness of breast cancer screening programs, is driving the market growth. Nonetheless, unspecific regulatory concerns, infection risks associated with breast biopsy procedures, and unclear reimbursement policies are factors that hinder market development. In addition, market limitations include the high cost of surgical procedures and the complications involved. Conversely, the advent of technologically advanced and minimally invasive breast biopsy devices is expected to create lucrative opportunities in the untapped market.

 

Breast Biopsy Market Segmentation

The global market for breast biopsy has been segmented based on product, technique type, guidance technology, and end-user.

Based on the product, the global market for breast biopsy has been classified as biopsy wires, biopsy needles, biopsy tables, guidance systems, and others.

Based on technique type, the global market for breast biopsy has been classified into fine needle aspiration biopsy, core needle biopsy, biopsy markers, surgical biopsy, MRI-guided core needle biopsy, sentinel node biopsy, and wire localization. Further, core needle biopsy is divided into needle biopsy, stereotactic core, ultrasound-guided core biopsy, freehand core-needle biopsy, and vacuum-assisted biopsy. Surgical biopsy is divided into incisional biopsy and excisional biopsy.

Based on guidance technology, the global market for breast biopsy has been classified into CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and other image-guided breast biopsy (PET and thermography).

Based on end-user, the global market for breast biopsy has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and others.

 

Breast Biopsy Market Regional Analysis

Regionally, the global market for breast biopsy has been segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. 

North America is projected to have the highest market share owing to the early adoption of advanced medical technologies and the continued growth of companies operating in cancer diagnostics. The global market for breast biopsy is primarily based on North America and Europe, which account for more than 50 % of the market share.

The European market is projected to have the second-highest market share, as breast cancer is the most prevalent in the United Kingdom and Belgium. As per Cancer Research UK, 55122 new cases of invasive breast cancer were diagnosed in 2015.

The Asia Pacific region is also expected to rise in the near future due to access to appropriate treatment facilities, growing demand for advanced technologies, higher acceptance rates, growing government initiatives, and increasing healthcare expenditure.

The global breast biopsy market in the Middle East and Africa is projected to account for the lowest share of the global breast biopsy market due to underdeveloped healthcare, lack of technical knowledge, and inadequate medical facilities.

 

Breast Biopsy Market Key Players

Some of the major players identified by MRFR in the global breast biopsy market are Leica Biosystems, NuVue Therapeutics, Argon Medical Devices, Inc., C.R. Bard Inc., Becton, Dickinson and Company, Devicor Medical Products Inc. Hologic Inc. Argon Medical Devices, Encapsule Medical Devices LLC., Cook Medical Incorporated, Johnson & Johnson, Galini SRL, Intact Medical Corporation, Hologic Inc., Conceptus INC, Karl Storz GmbH & Co. Kg, GE Healthcare.

Browse Complete Report @  https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288 

 Read more Reports

Medical Case Management Market

Compression Therapy Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Biosimilars Market Counting 7.5% CAGR up to 2025 | By Type : Biopsy Based, Endoscopy Based, Imaging Procedure and others | MRFR

Market Synopsis
Market Research Future (MRFR) postulates that the global biosimilars market is predicted to garner USD 3.35 billion, grabbing a CAGR of 26% throughout the forecast period (2017-2023). The augmenting incidences of several chronic diseases are estimated to favor the market growth. Biosimilars are referred to as a biological medical product which are identical copies of the original medical product. They are generally derived from a plant, bacteria, yeast, and other several processes. Biosimilars are neither generics nor treated like generic drugs. Also acknowledged as bio-pharmaceuticals, biosimilars differ from generics in the manufacturing process. They are produced by two main processes, recombinant DNA technology and controlled gene expression.
Market Potential and Pitfalls
With the augmenting incidences of several chronic diseases, growing demand for cheap medical products, and strategic collaborations leading to clinical trials and enhanced productivity, the global biosimilars market is estimated to flourish throughout the appraisal period. Biosimilars are extensively used in the treatment and prevention of chronic diseases like cancer, diabetes, autoimmune disease, cardiovascular diseases (CVDs), kidney failure, rheumatoid arthritis, hematological disease, hormone growth deficiency, and infectious disease. This is likely to create momentum to the market growth during the estimated period. Also, with the growth in the geriatric population, the demand for biosimilars is expected to trigger.
Biosimilars are constantly gaining prominence over other conventional biologics due to lesser cost as compared to the parent biological drugs. Moreover, different private and government bodies are promoting the use of biosimilars over synthetic drugs and conventional biologics, which is further propelling the growth of the market across the globe. Also, with the rapid growth in the pharmaceutical sector combined with the high cost of existing biological drugs, the market is anticipated to boom. 
On the contrary, physician skepticism coupled with the lack of awareness regarding biosimilars is some of the top barriers likely to vitiate the market growth in the coming years. Additionally, complexity and high manufacturing cost can act as roadblocks to the mainstream production of biosimilars. Despite such hiccups, discounted prices of biosimilars will impact the overall biosimilar sales, as patients are the key beneficiaries.
Global Biosimilars Market: Segmental Analysis
The global biosimilars market has been segmented on the basis of product, application, and manufacturing.
By mode of product, the global biosimilars market has been segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and others. Among these, the recombinant glycosylated proteins segment is anticipated to occupy the largest share and is likely to retain its dominance. The growth is credited to the wide therapeutic area of such proteins coupled with the presence biosimilar version of monoclonal antibodies at much lower rates. 
By mode of application, the global biosimilars market has been segmented into oncology, immune diseases, blood-related disorders, and others.
By mode of manufacturing, the global biosimilars market has been segmented into contract manufacturing and in-house manufacturing. Among these, the in-house manufacturing is presumed to occupy the largest share owing to the rising demand for cost-effective biosimilar products due to the augmenting incidences of several chronic diseases.
Regional Insights
Geographically, the biosimilars market span across regions namely, Europe, Asia Pacific, North America, and the Middle East & Africa.
Among all the regions, the European region is likely to dominate the global biosimilars market and is estimated to retain its dominance in the coming years. The growth is credited to the rising prevalence of diseases coupled with the growth in the geriatric population in this region. Moreover, advanced medical research and technological advancements are further triggering the demand for biosimilars in this region. The growth in the regional market is likely to be stimulated by patent expiry of biologic products combined with the launch of new biosimilars and the advent of new market participants.
The North American region is predicted to occupy the second largest share in the global market owing to technological advancements and extensive medical research. The market is mainly driven by the presence of large research labs such as Amgen, Sandoz, Teva Pharmaceutical, and others.
The Asia Pacific region is anticipated to emerge as the fastest-growing region owing to the immense economic development coupled with the booming biotechnology companies in this region. The country-specific markets in this region generating maximum revenue are India, Australia, South Korea, Japan, and China.
Industry Updates
February 19, 2019: Sandoz, a developer of biosimilar has recently announced the launch of their biosimilar adalimumab, Hyrimoz, in Spain. This biosimilar, referencing Humira, was authorized in the European Union for sale in July 2018. It has been approved for indications of reference adalimumab and is available in 40 mg doses for subcutaneous injection in pre-filled pen or a syringe form.
Competitive Dashboard
The prominent players operating the global biosimilars market are Biocon Ltd. (India), Eli Lilly (U.S.), Novartis (Switzerland), Celltrion Inc. (South Korea), Dr. Reddy’s Laboratories Ltd. (India), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Sandoz International GmbH (Germany), Astra Zeneca (U.K.), Amgen Inc. (U.S.), Samsung Bioepis (South Korea), F. Hoffmann-La Roche Ltd. (Switzerland), and Accord Healthcare (U.K.).
Read Complete Report @ https://www.marketresearchfuture.com/reports/biosimilars-market-1329 
Related Reports
Atrial Fibrillation Market
Breast Biopsy Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details